How Does Medtronic Make its Money?
Medtronic is the world’s largest pure-play medical device company, operating across four segments: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Founded in 1949 as a pioneer in cardiac pacemakers, the company now offers products ranging from heart valves and spinal implants to insulin pumps and surgical robots. Medtronic serves hospitals, physicians, clinicians, and patients in more than 150 countries. The company has been in a multi-year transformation effort to accelerate innovation and improve operational execution after a period of underperformance.
Medtronic (MDT) Business Model
Medtronic operates in the medical devices sector. Below is a summary of Medtronic’s revenue streams, how the company generates income, and the key financial metrics from its most recent annual report. This breakdown uses data from Medtronic’s 2024 fiscal year filings with the SEC.
Medtronic Competitors
Medtronic’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Boston Scientific, and Abbott Laboratories. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Medtronic stacks up by comparing their revenue breakdown, margins, and growth metrics.
Medtronic Competitors
Medtronic’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Boston Scientific, and Abbott Laboratories. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Medtronic stacks up by comparing their revenue breakdown, margins, and growth metrics.
Medtronic Competitors
Medtronic’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Boston Scientific, and Abbott Laboratories. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Medtronic stacks up by comparing their revenue breakdown, margins, and growth metrics.
Medtronic Competitors
Medtronic’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Boston Scientific, and Abbott Laboratories. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Medtronic stacks up by comparing their revenue breakdown, margins, and growth metrics.
Medtronic Competitors
Medtronic’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Boston Scientific, and Abbott Laboratories. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Medtronic stacks up by comparing their revenue breakdown, margins, and growth metrics.
Medtronic Competitors
Medtronic’s key competitors and comparable public companies in the medical devices sector include Stryker, Intuitive Surgical, Boston Scientific, and Abbott Laboratories. Each of these companies competes for market share, investor attention, and revenue in overlapping segments. See how Medtronic stacks up by comparing their revenue breakdown, margins, and growth metrics.
Revenue Breakdown
| Segment | 2024 | 2023 | YoY Growth |
|---|---|---|---|
| Cardiovascular | $12,300 | $11,600 | +6.0% |
| Neuroscience | $9,800 | $9,400 | +4.3% |
| Medical Surgical | $8,600 | $8,200 | +4.9% |
| Diabetes | $2,700 | $2,500 | +8.0% |
| Total Revenue | $33,400 | $31,200 | +7.1% |
Cardiovascular — 37% of Revenue
Neuroscience — 29% of Revenue
Medical Surgical — 26% of Revenue
Diabetes — 8% of Revenue
Income Statement Overview
| Metric | 2024 | 2023 |
|---|---|---|
| Total Revenue | $33,400 | $31,200 |
| Cost of Revenue | $11,300 | $10,700 |
| Gross Profit | $22,100 | $20,500 |
| Operating Expenses | $14,600 | $13,800 |
| Operating Income | $7,500 | $6,700 |
| Net Income | $4,700 | $3,700 |
All values in millions USD unless otherwise stated.
Key Financial Metrics
- Gross Margin: 66.2%
- Operating Margin: 22.5%
- Revenue Growth: 7.1%
Is Medtronic Profitable?
Yes, Medtronic is profitable. The company reported net income of $4,700 on total revenue of $33,400. With an operating margin of 22.5%, Medtronic demonstrates solid profitability for the medical devices sector. The gross margin of 66.2% reflects Medtronic’s pricing power and cost structure.
What to Watch
- Hugo robotic-assisted surgery platform launch and competitive response to Intuitive Surgical
- Diabetes segment growth with next-generation insulin pumps and CGM integration
- Cardiovascular pipeline including transcatheter aortic valve replacements
- Operational improvement initiatives to expand margins and accelerate growth
Medtronic (MDT) Financial Summary
Medtronic (MDT) is a medical devices company that generated $33,400 in total revenue in fiscal year 2024. Revenue grew 7.1% year-over-year. The company earned $4,700 in net income, making it profitable. For a deeper look at Medtronic’s revenue breakdown, business segments, and financial performance, review the detailed analysis above.